Genetic polymorphisms in coding genes play an important role when using mouse inbred strains as research models. They have been shown to influence research results, explain phenotypical differences between inbred strains, and increase the amount of interesting gene variants present in the many available inbred lines. SPRET/Ei is an inbred strain derived from Mus spretus that has ∼1% sequence difference with the C57BL/6J reference genome. We obtained a listing of all SNPs and insertions/deletions (indels) present in SPRET/Ei from the Mouse Genomes Project (Wellcome Trust Sanger Institute) and processed these data to obtain an overview of all transcripts having nonsynonymous coding sequence variants. We identified 8,883 unique variants affecting 10,096 different transcripts from 6,328 protein-coding genes, which is about 28% of all coding genes. Because only a subset of these variants results in drastic changes in proteins, we focused on variations that are nonsense mutations that ultimately resulted in a gain of a stop codon. These genes were identified by in silico changing the C57BL/6J coding sequences to the SPRET/Ei sequences, converting them to amino acid (AA) sequences, and comparing the AA sequences. All variants and transcripts affected were also stored in a database, which can be browsed using a SPRET/Ei M. spretus variants web tool (www.spretus.org), including a manual. We validated the tool by demonstrating the loss of function of three proteins predicted to be severely truncated, namely Fas, IRAK2, and IFNγR1.
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bioinformatics | genomics | mouse | mutations | inflammation T he normal function of a given protein in physiology, disease, or development is generally understood by studying the phenotype of a variant form of this protein. This principle is based on the general rule in genetics that we must "study the abnormal to understand the normal." Hence, introducing and detecting genetic variance are essential. A plethora of technologies have been developed to generate mutations in the genomes of a selected group of model organisms. The mouse is undoubtedly the favorite mammalian model species and, also in mice, techniques have been established that allow mutagenesis of the genome, yielding gain-or loss-of-function mutations, missense mutations, nonsense mutations, knockin alleles, deletions, and so forth (1) . By and large, the available technologies use embryonic stem cells and early embryos and require specific training and tools. Additionally, these technologies are expensive, slow, have low efficiency, and often show off-target effects. Even the recent revolutionary clustered regularly interspaced palindromic repeats (CRISPR)-associated (Cas9) technology has limitations and off-target effects (2) . Besides these targeting techniques, also random mutagenesis, for example using the chemical mutagen ethylnitrosourea (ENU), has increased the number of available mutant mouse strains to many thousands, and many of these have shown their value for the mouse community (3) . Besides the problems of generating mouse mutants, there are also issues with phenotyping, keeping mouse colonies alive, archiving them, and distributing mutant strains to interested users (4) .
Since Clarence Little showed in the early 20th century that the principle of inbreeding also applies to mice, several hundred inbred mouse strains have been generated (5) . Some of these strains display specific phenotypes that are the result of a mutant gene, and in several cases have formed the basis for identifying this mutant allele or opening a new field of research. A wellknown example is C3H/HeJ mice, which resist inflammation induced by lipopolysaccharide (LPS) because of a missense mutation in the Tlr4 gene, which codes for Toll-like receptor 4 (TLR4) protein (5) . In another example, MRL/lpr mice were found to develop lupus erythematosus because of an insertion in Fas, the gene coding for the death receptor Fas (first apoptotic signal) (6) . Such examples illustrate that the available inbred mouse strains may form a potentially very rich source of spontaneously arisen variants of alleles, and that this rich source remains insufficiently used.
Since the availability of deep-sequencing techniques, wholegenome sequences of several mouse strains have been generated. The Wellcome Trust Sanger Institute has decided to obtain highquality sequences of 36 commonly used inbred mouse strains and make the data available to the scientific community. We decided to study the sequences of the protein-coding genes of the mouse inbred strain SPRET/Ei, and compared the sequences with C57BL/6J, the standard mouse strain. SPRET/Ei is a relatively Significance Mouse genome sequences have been generated of tens of inbred strains. We here describe a user-friendly bioinformatics tool for revealing the sequence variations in protein-coding genes in one or more inbred strains and predicting which proteins are significantly different compared with those of the reference genome of C57BL/6J inbred mice. The analysis of truncated proteins in the strain SPRET/Ei, as an example, results in a user-friendly PDF file. This information is essential for interpreting biological data obtained using a given inbred strain, and confirms that inbred lines are a rich source of variant alleles of protein-coding genes, including knockout alleles. recent inbred strain, derived from Mus spretus, a species of mice closely related to Mus musculus, the species that had been used to generate C57BL/6J and many more strains. Because of the evolutionary distance of about 1.5 million y between M. spretus and M. musculus, a rich degree of genetic polymorphism is found between SPRET/Ei and C57BL/6J, so that 1 bp every 100 bp is different (7) . Moreover, SPRET/Ei mice have attracted interest because they display interesting and robust phenotypes. For instance, they are long-lived (8) , and resist the development of multiple forms of cancer or lethal inflammation induced by high doses of LPS or of the cytokine tumor necrosis factor (TNF) (9) (10) (11) .
In this study, we used the variant data of the Mouse Genomes Project made available by the Wellcome Trust Sanger Institute consisting of information about SNPs and insertions/deletions (indels). More specifically, the data of the M. spretus-derived inbred strain SPRET/Ei were used in this study. We made a list of all protein-coding genes that have nonsilent mutations compared with the C57BL/6J reference genome. We determined the final combined outcome, per transcript, of all mutations present and stored all results in a database that is easily accessible. We validated the tool by demonstrating the loss of function of three proteins predicted to be severely truncated, namely Fas, IRAK2 (Interleukin-1 receptor-associated kinase 2), and IFNγR1 (interferon-gamma receptor 1). This tool can be applied to any inbred strain, the data of which are made available in public databases.
Results
Comparative Genomics of the SPRET/Ei and C57BL/6J Reference Genomes. To investigate the genes most likely involved in the extreme phenotypes of the SPRET/Ei mice and to obtain a list of all deviant proteins compared with C57BL/6J, we used the genomic sequences of the C57BL/6J and SPRET/Ei strains released by the Wellcome Trust Sanger Institute (www.sanger.ac. uk/science/data/mouse-genomes-project). A filtering was done for all SPRET/Ei sequence variants that were predicted to affect protein-coding sequences compared with C57BL/6J. This yielded 8,883 sequence variants, of which 89 were found to be heterozygous. Of these heterozygous variants, 30 have two different variations, one per allele, both different from the reference sequence. If the latter variations are counted as two unique events, the total number of differences found between C57BL/6J and SPRET/Ei coding sequences increases to 8,913. These 8,913 variations are composed of 3,711 SNPs and 5,202 indels. We retained the variants that have a predictable effect on the final protein product for downstream analysis, namely SNPs affecting a stop codon, insertions or deletions in an exon, and missense SNPs. Our focus in particular was on variations that led/could lead to a premature termination of translation: stop-gain SNPs and frameshift indels (Fig. 1) . The effect of these variants on the final protein product can be very large if they occur early in the transcript. All of the stop-gain SNPs and about 40% of the frameshift-causing indels resulted in an early termination of the encoded protein. These truncations range from one amino acid to almost complete deletion. There were a total of 1,848 transcripts leading to a final protein product that was truncated to some degree. In Fig. 2A , we display the distribution of the relative size of the truncations of SPRET/Ei proteins. Because the probability that an early termination will lead to loss of function increases with the size of the deleted portion, transcripts were divided into groups according to the amount of sequence lost. Among the 1,848 transcripts affected by an early stop there were 1,149 transcripts (originating from 865 genes) where the introduction of a premature stop codon reduced the length of the final protein product by 20% or more. For 457 transcripts (355 genes), the truncation size exceeds 75% of the normal C57BL/6J reference protein length (Fig. 2B ).
Stop-Gain Variants. The 865 genes having one or more transcripts with a large truncation were subjected to a more detailed analysis. A functional Gene Ontology (GO) enrichment analysis revealed an almost 10-fold enrichment of genes related to response to pheromone (P = 1.24e-10) compared with what would be expected by chance. The responsible genes almost all belong to the olfactory receptor family of genes. We also detected a significant enrichment for genes involved in immune system process (1.7-fold; P = 0.0038). For example, the following genes in SPRET/Ei led to significantly shorter proteins compared with C57BL/6J: Ccl26, Cxcr1, Ackr2, Xcl1, Trem2, Fas, Il17re, Irak2, Cd244, Cr1l, Ifngr1, Lilrb4, Gstt2, A4galt, and Il1f9/Il36g. The presence of nonfunctional or only partially functional genes related to the immune system may help explain previously observed effects, such as resistance to LPS (9) . An overview of all proteins that are truncated in SPRET/Ei compared with C57BL/6J is found in Dataset S1. Based on the size of the truncation and the function of the proteins in inflammation, we selected three genes of which the protein is significantly truncated in SPRET/Ei to validate the predictive value of our tool. The genes are Fas (in SPRET/Ei, encoding a protein of 60 rather than 327 amino acids), Irak2 (459 rather than 622 amino acids), and Ifngr1 (190 rather than 477 amino acids).
Data Availability. The data for the SNP/indel variants for all 8,883 transcripts can be obtained per gene from the M. spretus variants web tool at www.spretus.org. Data come in a table format as described previously by searching by gene name. Affected transcripts can be found on the gene details page. Here a PDF report can also be downloaded including essential information per transcript such as a grouped GO annotation, the size of the truncation (if any), and a sequence alignment of the affected positions.
Truncation of Fas Protein Completely Protects SPRET/Ei Mice Against
Jo2-Induced Lethality. To test the functionality of the predicted deviant Fas protein in SPRET/Ei mice, we used the agonistic anti-Fas antibody Jo2. Jo2 will bind to Fas and a lethal hepatitis will be induced (12) . Intraperitoneal injection of Jo2 rapidly killed C57BL/6J mice within 6.5 h, but the SPRET/Ei mice were resistant against this lethality (Fig. 3A) . Moreover, SPRET/Ei mice did not even show a drop in body temperature after injection (Fig. 3B) . To assess the degree of liver injury, the mice were killed 6 h after injection for the analysis of their liver and serum. This was the moment the C57BL/6J mice became moribund. As shown in Fig. 3C , aspartate transaminase (AST) and alanine transaminase (ALT) levels in serum, which are measures for hepatotoxicity, were significantly increased in Jo2-treated C57BL/6J mice, whereas there was no increase measurable in Fig. 1 . Overview of the distribution of variants affecting the coding sequences of SPRET/Ei genes. Fifty-one percent of all events are in-frame indels. Stop-gain and frameshift mutations (lifted slices) make up 42% of all events; these were also the variations we focused on further. Stop-loss and missense variants made up the last 7% of all variants present.
SPRET/Ei mice compared with untreated SPRET/Ei mice. Histological examination of liver tissue of Jo2-treated mice showed no signs of liver damage in SPRET/Ei mice compared with C57BL/6J mice. Hematoxylin and eosin staining showed prominent apoptotic lesions in C57BL/6J mice in contrast to the livers of SPRET/Ei mice, which were completely preserved without any signs of hepatic apoptosis (Fig. 3D) . Together, these findings indicate that SPRET/Ei mice are completely protected against Fas-induced hepatotoxicity.
IRAK2 and IFNγR1 Truncation Leads to Aberrant Response to IL1β and
IFNγ in SPRET/Ei Mice. The genomic comparison between C57BL/6J and SPRET/Ei mice also revealed premature stop mutations leading to truncated IRAK2 and IFNγR1. IRAK2 functions as an adaptor protein that becomes associated with the interleukin 1 receptor (IL1R) upon IL1β stimulation and is reported to participate in the up-regulation of NF-κB induced by IL1β (13) . IFNγR1, on the other hand, is the ligand-binding subunit that heterodimerizes with the signal-transducing subunit IFNγR2 when the ligand IFNγ is present to form a functional signaling receptor (14, 15) .
To determine the consequences of truncated IRAK2, C57BL/6J and SPRET/Ei mice were injected with IL1β, and spleen and liver were isolated to assess the NF-κB response in those organs after injection. As illustrated in Fig. 4 A and B, both in liver and spleen, the NF-κB response-illustrated by Il6 and Tnfaip3 expression-was abolished in SPRET/Ei mice compared with C57BL/6J mice, which exerted full expression of these genes. Truncated IRAK2 also impacted the systemic inflammation. Although IL6 levels were increased in IL1β-injected SPRET/Ei mice compared with PBS-injected mice, levels were significantly lower than those in IL1β-injected C57BL/6J mice (Fig. 4C) .
To investigate the effects of IFNγR1 abrogation, mice were injected with its ligand, IFNγ. We investigated the expression of typical IFN-stimulating genes (ISGs) 2 h after injection of IFNγ. In spleen, we could not detect any up-regulation of the tested ISGs 2 h after injection, not in C57BL/6J nor in SPRET/Ei. By contrast, in liver, we detected a clear induction of Il12rb1 and Il23 in IFNγ-injected C57BL/6J mice that was not present in SPRET/Ei mice (Fig. 4D) . Also, systemically, an aberrant IFNγ signaling led to reduced IL6 levels in SPRET/Ei mice that were significantly lower than those in C57BL/6J mice (Fig. 4E) . Based on these results, we can conclude that IL1β and IFNγ signaling, mediated by IRAK2 and IFNγR1, respectively, are abolished in SPRET/Ei mice due to the predicted presence of stop mutations in those genes.
Discussion
Efficient and user-friendly analysis of whole-genome sequence data is both a necessity and a challenge. Obviously, genome data contain a treasure of information, and there are several good reasons why the detailed study of the sequence of the proteincoding genes and their functional annotation of the most popular mouse strains should be easily accessible. A first reason concerns the fact that mouse strains may contain abnormal alleles, which can compromise the interpretation of the phenotype that arises from the targeted mutation of interest. Most knockout (KO) alleles have been generated in ES cells with a 129 genetic background, whereas most scientists want to study their knockout allele in a strain that is better-standardized, for example, C57BL/6J. Thus, scientists backcross the mutant allele from the donor strain, for at least 5 (but preferentially 10) generations into the acceptor strain, C57BL/6J. However, they usually fail to realize that a significant part of the donor genome (129) still surrounds the mutant allele, called passenger DNA, and this may contain deviant alleles of the donor strain. As we recently published (16), a notorious example is the caspase 1 KO mouse, generated in 129 ES cells, which in turn appeared to contain a defective caspase 11 gene closely linked to the caspase 1 gene (Casp1), and thus scientists have been studying caspase 1 phenotypes in mice that appeared to be caspase 11-deficient as well, even after successive backcrossing (17) .
A second important reason for knowing the functionality of all protein-coding alleles of a mouse strain is to provide an explanation for the different penetration or phenotype observed by a targeted allele when studied in different genetic backgrounds. Some spectacular cases have been reported, which are highly likely to derive from the activities of genes in the genetic background, namely by modifier alleles, and the identification of these alleles may be of extreme importance (18). . The bins go from 0 to 0.1, meaning that the SPRET/Ei protein is at most 10% of the length of the C57BL/6J protein (e.g., 100 AA→10 AA), to 0.9-1, indicating a reduction of the SPRET/Ei protein length to 90% or more of the C67BL/6J length (e.g., 100 AA→90 AA). (B) Distribution of 1,848 transcripts (from 1,410 genes) according to truncation size. Six hundred ninety-nine of the transcripts (38%) truncated in SPRET/Ei produce a protein that is at most 20% shorter than the C57BL/6J protein. About the same number of transcripts (692) code for a protein that is 20-75% shorter in SPRET/Ei than in C57BL/6J. Finally, the remaining 457 transcripts code for a protein that has an extreme truncation, with a loss of at least 75% of the WT AA sequence.
Finally, in the search for a saturation of the mouse genome with mutant alleles of protein-coding genes, the mouse community has already generated many thousands of mutant mice using a variety of technologies. High-throughput mutagenesis programs, such as those based on chemical mutagenesis, have led to many thousands of mutants, usually also several per gene. However, there is still room for more mutant alleles. Also in this sense, a comprehensive overview of the sequences of all genes (also non-proteincoding) of the major inbred mouse strains that have been sequenced would be a very interesting piece of information.
The Wellcome Trust Sanger Institute has obtained high-quality genome sequences of 36 inbred mouse strains (19) (www.sanger.ac. uk/science/data/mouse-genomes-project). We here describe a tool, available online, where all genes of the SPRET/Ei strain having variations resulting in changes to the final protein product can be found. We have downloaded and processed the data from the Wellcome Trust Sanger Institute and compiled a list of all variants affecting the coding sequence and all genes affected. Although several tools exist to browse variant data at dbSNP (www. ncbi.nlm.nih.gov/projects/SNP/), Wellcome Trust Sanger Institute (www.sanger.ac.uk), Mouse Genome Informatics (MGI) (www. informatics.jax.org/), and others, ours has several advantages. None of the tools we found takes the effect of the variants to the protein level to identify potentially nonfunctional proteins. The data we used can be browsed on the website from the Mouse Genomes Project (Wellcome Trust Sanger Institute) itself, but our tool is less complex to use and was one of the reasons we made our own www.spretus.org website. In addition, we also used the most recent data, which do not need to be validated, as our goal was to identify possible nonfunctional proteins in SPRET/Ei. The advantage of using the latest data is illustrated by comparing our findings for the Fas gene with the results obtained with the tool from MGI. This tool uses SNP data from 2013, which explains why it failed to find any SNPs in the SPRET/Ei Fas gene, whereas we clearly show a loss of function. All our results were stored in a database that can be searched by the public (www.spretus.org). In addition, we also determined the final result of all mutations affecting a transcript, as many transcripts are affected by multiple events. We found that SPRET/Ei, a mouse strain known to contain a very significant number of genetic polymorphisms compared with C57BL/6J (7), indeed expresses a wealth of genes coding for proteins that differ in amino acid (AA) sequence or length. Many proteins, for example, are significantly shorter than the C57BL/6J ortholog, because their genes contain a premature stop codon in the reading frame. This is the case in no fewer than 1,848 proteins, of which 457 proteins are more than 75% shorter than the C57BL/6J version. To validate our method, we picked three examples of such stop-gained proteins and tested whether they were indeed nonfunctional in SPRET/Ei mice. These three examples are coding for the death receptor Fas (Fas), the inflammation adaptor molecule IRAK2 (Irak2), and the major IFN-gamma receptor (Ifngr1). These three proteins are all involved in inflammation and immunity and lacked 81.7%, 26.2%, and 60.2%, respectively, of the canonical AA sequence due to the nonsense mutation. In all cases at least one protein domain, as defined in the UniProt database (www.uniprot.org), of the protein was affected (partial or complete deletion).
Fas (CD95) is a member of the TNF-R family, a group of type I transmembrane proteins (20) . Fas contains a "death domain" in its cytoplasmic region, which is essential for its induction of apoptosis. Fas ligand (FasL) is the only known physiological ligand of Fas. Fas/FasL signaling plays a critical role in lymphocyte homeostasis (21) . Mice with mutations in Fas (lpr mice) or FasL (gld) show massive lymphadenopathy and systemic autoimmunity and glomerulonephrosis. lpr mice are a useful model for studying Bars represent mean ± SEM; *, 0.01 ≤ P < 0.05; ***, 0.001 ≤ P 0.0001; ****P < 0.0001; ns, not significant; n = 5-17. Black, C57BL/6J; gray, SPRET/Ei. systemic lupus erythematosus (22) (23) (24) . Jo2 is an anti-mouse Fas agonistic monoclonal antibody that leads, upon injection in mice, to acute, lethal, massive apoptotic hepatitis (12, 25) . Because SPRET/Ei mice lack most of the Fas protein sequence, as found using the Spretus tool, we indeed found that, in contrast to C57BL/6J mice, they completely resisted Jo2-induced fulminant liver failure. This was reflected in the complete absence of AST and ALT elevation in serum, and also histopathological analysis of the liver clearly showed that SPRET/Ei mice were protected against necrosis induced by Jo2. SPRET/Ei is not the only mouse inbred line that has no expression of Fas. Also, MRL/lpr mice are devoid of Fas expression, due to a transposon insertion in the Fas gene (22) . Because of the failure of lymphocytes to be killed by apoptosis after an immune response, these mice develop an autoimmune pathology characterized by swollen lymph nodes, anti-DNA antibodies in the urine, and premature death. SPRET/Ei mice do not develop such a lupus phenotype, and are long-lived. There is no clear reason for this difference with MRL/lpr, and we speculate that other gene differences, forming the basis of the obvious antiinflammatory status of SPRET/Ei and their lack of cell proliferation in numerous tumor models, protect them from the development of the lupus phenotype.
Additionally, we tested the functionality of the predicted genes Irak2 and Ifngr1 in SPRET/Ei mice. Irak2 KO mice did not show an overt phenotype, but showed impaired NF-κB signaling following TLR stimulation (26) . Ifngr1 KO mice also had no overt defects in their immune system or anomalies; however, they were more susceptible to certain viral infections or infection with intracellular bacteria (27) . Also, loss of function of human IFNγR1 has been reported and associated with severe susceptibility to poorly virulent mycobacteria that can be fatal in childhood (14) , and the severity of this sensitivity was correlated with the degree of deficiency.
The lack of functionality of IRAK2 was tested by injecting IL1β into SPRET/Ei mice, and we studied gene induction in the spleen and liver that results from activation of IL1 receptor followed by IRAK2 activation and gene induction of the NF-κB-dependent genes Il6 and Tnfaip3. As expected from a deficiency in Irak2, decreased induction of these genes and of IL6 appearance in the serum was observed. The partial response of SPRET/Ei in the absence of functional IRAK2 is compatible with the fact that IRAK1 and IRAK2 are cooperative but redundant and that IRAK1 is especially important in the early response to IL1 and IRAK2 to later responses (26) . No other defects were found in SPRET/Ei proteins that mediate the IL1 response.
Equally, lack of response was found when IFNγR1 was stimulated after injection of IFNγ into SPRET/Ei mice, and induction of the IFNγ-stimulating response genes IL12rb1 and IL23r was studied, as well as IL6 release in serum of mice. Again, we observed an impaired IFNγ response in SPRET/Ei mice compared with C57BL/6J mice. This impaired response may be (partly) responsible for the poor response of SPRET/Ei mice in models of arthritis (7). Also, the response to IFN described here was not completely absent, however, which may be due to IFNγR2 activities, either directly responding to IFNγ or via a soluble IFNγR1, which in theory could be produced in SPRET/Ei, as the protein in this strain lacks all intracellular domains and the transmembrane domain.
These examples confirm that the predicted deficiency of SPRET/Ei in the function of Fas, IRAK2, and IFNγR1 is validated. The tool described here is also useful for finding candidate deviant genes that may be linked to particular chromosomal loci (for an overview, see Dataset S1) and phenotypes described for the SPRET/Ei strain. For example, the resistance of SPRET/Ei mice was linked to a locus (110-140 Mb) on the X chromosome, which, according to the current analysis, could be due not only to the gene Tsc22d3, as described by Pinheiro et al. (10), but Table S1 . Bars represent mean ± SEM; *, 0.01 ≤ P < 0.05; **, 0.001 ≤ P < 0.01; ***, 0.001 ≤ P 0.0001; ****P < 0.0001; n = 5-17. Black, C57BL/6J; gray, SPRET/Ei. also to Pim2, an inflammatory protein that has lost 84% of its protein sequence in SPRET/Ei (Dataset S1). The Mouse Phenome Database, generated and hosted by the Jackson Laboratory (MPD; phenome.jax.org), shows a number of obvious phenotypes in SPRET/Ei mice when taking C57BL/6J as a reference. Some of the gene variations that we identified in the SPRET/Ei genome can be directly correlated to SPRET/Ei phenotypes. We give two examples here. First, the MPD yields that the number of white blood cells (WBCs) is lower in SPRET/Ei mice than in C57BL/6J mice. When we select all genes that code for truncated proteins in SPRET/Ei and perform an Ingenuity Pathway Analysis (IPA analysis; www.ingenuity.com), the IPA predicts the number of various WBC (neutrophils, lymphocytes) types to be indeed negatively affected in SPRET/Ei mice. Second, the MPD also shows differences in blood cholesterol level, with SPRET/Ei mice having a lower LDL level. Indeed, based on the list of truncated proteins, IPA predicts the level of LDL in SPRET/Ei mice to be lower, only based on the list of genes. In conclusion, using the tools we describe here, lists can be easily generated containing genes that are expected to be defective in a given sequenced mouse strain.
Materials and Methods
For mice, reagents, and experimental procedures, see SI Materials and Methods. Animal experiments were approved by the institutional ethics committee for animal welfare of the Faculty of Science, Ghent University.
Bioinformatics Analysis of SNP and Indel Data. Our analyses were performed using Mouse Genomes Project data (28, 29) , v5 release (REL-1505-SNPs_Indels), from the Wellcome Trust Sanger Institute (ftp://ftp-mouse. sanger.ac.uk/REL-1505-SNPs_Indels/). The data in the variant files for indels (mgp.v5.merged.indels.dbSNP142.normed.vcf.gz) and SNPs (mgp.v5.merged. snps_all.dbSNP142.vcf.gz) were filtered to obtain all sequence variants present in the SPRET/Ei strain compared with C57BL/6J. This list was further filtered so that only variants affecting protein-coding genes were retained. The filtering was done based on the Sequence Ontology (SO) assigned by the Wellcome Trust Sanger Institute. The variants with the following SO annotations were retained: stop_gained, stop_lost, inframe_insertion, in-frame_deletion, frameshift_variant, splice_donor_variant, splice_acceptor_variant, and coding_ sequence_variant. We used the Ensembl annotation of the mouse genome to annotate the data on the gene and transcript level. Finally, we retained 8,883 variants affecting 10,096 unique transcripts from 6,328 different genes. For completion, intronic variants are also included in the database, but they were not included in any downstream analysis.
Development of an M. spretus Variants Web Tool. It is important that information about the SPRET/Ei coding sequence variants can be accessed with ease. To this end, we developed an M. spretus variants web tool, which is available to the public at www.spretus.org, to allow the data to be browsed in a user-friendly way. A brief description of the tool is provided, and a manual can be found at www.spretus.org by clicking on "examples" and on "here." The manual is also presented in SI Spretus.org Tool Manual, and a brief outline of the procedure is shown in Fig. S1 . The M. spretus variants web tool allows searches in three different ways: by gene name, location, or GO term. An entered keyword is matched against all official gene symbols or GO annotations in the database, depending on the search type. In the case of a gene search, all perfect and partial gene name matches are returned, a GO search returns all terms found by a wildcard-based matching, and a region search returns all genes with a SNP/indel in the specified region. This is presented to the user in a table presenting the variant location, Ensembl ID, gene name, genomic location of the variant, reference nucleotide sequence (C57BL/6J), alternative nucleotide sequence (SPRET/Ei), and depth of sequencing, which can be used as a measure of reliability. The variant location is a link to the Mouse Genomes Project genome browser, where the variant can be visualized. Clicking the Ensembl ID shows a page with more detailed information for that gene. This also includes a per-transcript overview of all transcripts affected by a SNP or indel. This includes the sequence, position in the coding sequence (CDS) and protein, a quality score, and direct consequences of the variation. There is also an option to download a report for a gene as a PDF. This report is generated by a Perl script. It shows the combined effect of all variants on the transcripts of the gene. In case a new stop codon is introduced into the transcript, the region around this new stop will be included as a pairwise sequence alignment in the report.
Statistics. GO enrichment analysis was performed using the GOslim sets for molecular function, biological process, and cellular component, with all genes in the genome serving as the background. Functional annotations (GOSlim) for proteins were acquired from BioMart (www.Biomart.org). We corrected these analyses for multiple testing with the Bonferroni method. All GO terms with a P value ≤ 0.05 (after Bonferroni correction) were retained as significantly enriched. The experimental mouse data are presented as mean ± SEM. Data were analyzed with an unpaired t test, unless mentioned differently. Significance levels were calculated for differences between treated and untreated SPRET/Ei and C57BL/6J, as indicated (*, 0.01 ≤ P < 0.05; **, 0.001 ≤ P < 0.01; ***, 0.001 ≤ P 0.0001; ****, P < 0.0001).
